BLMH

Bleomycin hydrolase

The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B-aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity.

Associated with:

Alanine Transaminase
Albumin
Alkaline Phosphatase
Apolipoprotein A
Apolipoprotein B
Aspartate Transaminase
Basal Metabolic Rate
Basophils
BMI
C Reactive Protein
Calcium
Calcium Albumin Ratio
Chronic Obstructive Pulmonary Disease
Chronik Kidney Diesase
Creatinine
Cystatin C
Diastolic Blood Pressure
Eosinophils
Erythrocyte Sedimentation Rate
Estimated Glomerular Filtration Rate
Folate
Gamma Glutamyltransferase
Glucose
Granulocytes
HbA1c
Heartrate
Height
Hematocrit
Hemoglobin
High Density Lipoprotein Cholesterol
Hypertension
IgA
IGF1
Iron
Kidney Failure
Leukocytes
Low Density Lipoprotein Cholesterol
Lymphocytes
Metabolic Syndrome
Monocytes
Neutrophils
Platelet
Red Blood Cell Count
Reticulocytes
Severe Obesity (BMI > 35)
Systemic Lupus
Systolic Blood Pressure
Total Bilirubin
Total Cholesterol
Total Lean Muscle
Transferrin Saturation
Triglyceride
Type 2 Diabetes
Urea
Uric Acid
Vitamin D
Waist Circumference
Waist Hip Ratio
Weight
White Blood Cell
Whole Body Fat

Matrix Type

Plasma
Tissue/Cells

Gene Symbol

BLMH

UniProt ID

Q13867

REQUEST ASSAY

Request the BLMH Assay

Tell us a little more about your study so we can optimize the assay for your specific needs.

ASK A QUESTION

"*" indicates required fields

BLMH

Bleomycin hydrolase

Associated with:

Matrix Type

Gene Symbol

UniProt ID

Request the BLMH Assay

SERVICES

APPLICATIONS

PARTNERING

RESOURCES

ABOUT